Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
1.67
- 0.07 (-4.02%)
4:00 PM ET on May 26, 2017
Delayed at least 20 minutes.
Day High 1.79
Day Low 1.66
52-Week High 32.00
Volume 125,462
Print Friendly